Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 27, 2015 1:51 AM ET


Company Overview of Plandaí Biotechnology, Inc.

Company Overview

Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing two extracts, including Phytofare Catechin Complex, which is derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare Limonoid Glycoside Complex extracted from lemons that are sourced from plantations in South Africa. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. In addition, it intends to use its plantation leases to focus on the farming of whole fruits, vegetables, and live plant material. The company is based in...

1451 North 200 East

Suite 130C

Logan, UT 98102

United States

100 Employees



Key Executives for Plandaí Biotechnology, Inc.

Co-Founder, Chairman, Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer and Secretary
Age: 71
Total Annual Compensation: $117.5K
Vice President of Sales and Director
Age: 29
Total Annual Compensation: $95.0K
Vice President of Marketing and Director
Age: 45
Total Annual Compensation: $9.0K
Compensation as of Fiscal Year 2014.

Plandaí Biotechnology, Inc. Key Developments

Plandaí Biotechnology, Inc. announced delayed 10-Q filing

On 05/15/2015, Plandaí Biotechnology, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Plandaí Biotechnology, Inc. Announces its Entry into an Exclusive 3 Year Supply Agreement with USN Worldwide

Plandaí Biotechnology, Inc. announced its entry into an exclusive 3 year supply agreement with USN Worldwide. Pursuant to the contract, the Company will initially sell to USN commercial amounts of Phytofare(R) catechin complex for USN'S South African markets. Ultimately, the parties intend to expand USN's purchases globally into other territories in which USN operates. This agreement also allows USN to further control the input costs around production, while enhancing product efficacy by replacing the generic green tea extracts in its extensive stable of innovative and market leading products, with the clinically proven highly bioavailable Phytofare(R) catechin complex. This agreement gives Plandai the opportunity to cement its relationship with a long-term global customer who has a vision for growth and market expansion.

Plandaí Biotechnology, Inc. Announces Change of Independent Certifying Accountants

On April 22, 2015, Plandaí Biotechnology, Inc. accepted the resignation of Terry L. Johnson, CPA from his engagement to be the independent certifying accountant for the company. On April 22, 2015, the company's Board of Directors approved the engagement of Danielle M. Adams, CPA of Adams Advisory, LLC, as the company's independent accountant effective immediately to audit the company's financial statements and to perform reviews of interim financial statements.

Similar Private Companies By Industry

Company Name Region
ArgentumCidalElectrics Inc. United States
Matinas Biopharma, Inc. United States
Blue Heron Biotechnology, Inc. United States
Aura Biosystems, Inc. United States
Mosaic Biosciences, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Plandaí Biotechnology, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at